View Older Stories

Feb 24, 2026 12:32PM Illumina launches TruPath Genome sequencing technology

Feb 23, 2026 09:15AM Illumina announces NovaSeq X system upgrades over 18 months

Feb 6, 2026 10:01AM Stifel Reiterates Buy Rating on Illumina (ILMN)

Feb 6, 2026 06:28AM Canaccord Genuity Reiterates Hold Rating on Illumina (ILMN)

Feb 6, 2026 05:58AM Canaccord Genuity Reiterates Hold Rating on Illumina (ILMN)

Feb 5, 2026 04:16PM Illumina (ILMN) Tops Q4 EPS by 13c, provides guidance

Jan 26, 2026 05:15AM Illumina (ILMN) PT Raised to $150 at Canaccord Genuity

Jan 20, 2026 09:15AM Illumina receives CMS reimbursement for cancer genomic test

Jan 20, 2026 06:26AM Illumina (ILMN) PT Raised to $155 at Stifel

Jan 13, 2026 09:15AM Illumina launches billion cell dataset for drug discovery AI

Jan 13, 2026 09:03AM Illumina reports preliminary Q4 revenue of $1.16 billion, up 5%

Jan 6, 2026 09:15AM Illumina launches cloud-based multiomic research software platform

Dec 10, 2025 08:06AM Illumina (ILMN) Sees Multiple Growth Levers Over 3-5 Years - Stifel

Nov 12, 2025 12:00PM Illumina study finds whole-genome sequencing captures 90% of genetic signals

Nov 10, 2025 12:22PM Illumina reports 40 customers using protein prep solution across 16 sites

Nov 5, 2025 05:17PM China lifts export ban on Illumina effective November 10

Oct 31, 2025 03:32AM Illumina (ILMN) PT Raised to $112 at Canaccord Genuity

Oct 30, 2025 04:31PM Illumina (ILMN) Tops Q3 EPS by 17c; offers guidance

Oct 16, 2025 06:39AM Guggenheim Reiterates Buy Rating on Illumina (ILMN)

Oct 15, 2025 09:16AM Illumina constellation technology identifies hard-to-detect genetic variants

Oct 15, 2025 09:16AM Illumina launches 5-base solution for genomic and epigenomic analysis

Oct 14, 2025 01:42PM Illumina (ILMN) 2100 contracts of October 90 puts trade, share price down 4.2%

Oct 1, 2025 09:05AM Illumina launches BioInsight business for data and AI solutions

Oct 1, 2025 08:00AM BofA introduces Top 10 U.S. ideas for Q4 2025

Sep 23, 2025 09:15AM Illumina partners with pharma companies on KRAS cancer diagnostics

Sep 18, 2025 09:15AM Alnylam joins Alliance for Genomic Discovery genomic dataset

Sep 3, 2025 09:15AM Illumina launches protein prep assay for drug discovery research

Aug 1, 2025 10:15AM Illumina (ILMN) PT Raised at RBC Capital; 'Time For Investors To Re-Visit ILMN'

Aug 1, 2025 04:25AM Stocks expected to have increasing option volume: ILMN BOOT FIVN ROKU KLAC NET SVV BE TREE BOOT KLAC PARA CSX PLTR

Jul 31, 2025 04:22PM Illumina (ILMN) Tops Q2 EPS by 18c; offers guidance

Jul 30, 2025 09:15AM Illumina launches enhanced cancer research assay with faster results

Jul 11, 2025 08:55AM Scotiabank Downgrades Illumina (ILMN) to Sector Perform

Jul 9, 2025 05:05AM Citi Downgrades Illumina (ILMN) to Sell

Jul 8, 2025 07:21AM Evercore Lists Additions to TAP Outperform List of Life Science & Diagnostic Tools Names

Jul 7, 2025 09:02AM Bernstein on US Life Science Tools & Diagnostics: 'Why We're More Bullish...'

Jul 7, 2025 08:31AM iRhythm Technologies (IRTC) announces Board changes

Jun 24, 2025 09:56AM Bernstein Reiterates Market Perform Rating on Illumina (ILMN) Post SomaLogic Acquisition

Jun 23, 2025 07:15AM Illumina (ILMN) to acquire SomaLogic

Jun 23, 2025 07:06AM Standard BioTools (LAB) Sells SomaLogic to Illumina (ILMN)

Jun 10, 2025 02:59PM Illumina (ILMN) PT Raised to $99 at Canaccord Genuity Following CEO Podcast

Jun 9, 2025 08:25AM Piper Sandler on Illumina (ILMN): 'Near-Term Headwinds, but We're Optimistic About 26/27'

May 29, 2025 02:01PM Illumina (ILMN) unveils PromoterAI

May 28, 2025 09:15AM Illumina (ILMN) expands clinical oncology portfolio unlocking new standard of care and access to precision therapies

May 28, 2025 07:49AM Stifel Reiterates Buy Rating on Illumina (ILMN)

May 27, 2025 08:00PM Citi names 3 stocks as its new top picks in the Life Science sector

May 13, 2025 09:15AM Illumina (ILMN) Launches DRAGEN v4.4 powers clinical oncology research and multiomic applications

May 12, 2025 05:59AM Increasing unusual call option volume: PHAT CNH AXL RUN PPG SHLS AS AZUL ILMN

May 12, 2025 05:25AM Illumina (ILMN) PT Lowered to $87 at Canaccord Genuity

May 10, 2025 04:00PM These 2 sectors are under-owned, Barclays says and advises where to invest

May 9, 2025 09:44AM Illumina (ILMN) PT Raised to $89 at TD Cowen Despite a 'Difficult Macro'

View Older Stories